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We previously reported chromatographic evidence supporting the similarity of yellow chromophores isolated from aged human lens proteins,
early brunescent cataract lens proteins and calf lens proteins ascorbylated in vitro [Cheng, R. et al. Biochimica et Biophysica Acta 1537, 14–26,
2001]. In this paper, new evidence supporting the chemical identity of the modified amino acids in these protein populations were collected by
using a newly developed two-dimensional LC-MS mapping technique supported by tandem mass analysis of the major species. The pooled water-
insoluble proteins from aged normal human lenses, early stage brunescent cataract lenses and calf lens proteins reacted with or without 20 mM
ascorbic acid in air for 4 weeks were digested with a battery of proteolytic enzymes under argon to release the modified amino acids. Aliquots
equivalent to 2.0 g of digested protein were subjected to size-exclusion chromatography on a Bio-Gel P-2 column and four major A330nm-
absorbing peaks were collected. Peaks 1, 2 and 3, which contained most of the modified amino acids were concentrated and subjected to RP-
HPLC/ESI-MS, and the mass elution maps were determined. The samples were again analyzed and those peaks with a 104–106 response factor
were subjected to MS/MS analysis to identify the daughter ions of each modification. Mass spectrometric maps of peaks 1, 2 and 3 from cataract
lenses showed 58, 40 and 55 mass values, respectively, ranging from 150 to 600 Da. Similar analyses of the peaks from digests of the ascorbylated
calf lens proteins gave 81, 70 and 67 mass values, respectively, of which 100 were identical to the peaks in the cataract lens proteins. A total of 40
of the major species from each digest were analyzed by LC-MS/MS and 36 were shown to be identical. Calf lens proteins incubated without
ascorbic acid showed several similar mass values, but the response factors were 100 to 1000-fold less for every modification. Based upon these
data, we conclude that the majority of the major modified amino acids present in early stage brunescent Indian cataract lens proteins appear to arise
as a result of ascorbic acid modification, and are presumably advanced glycation end-products.
© 2006 Elsevier B.V. All rights reserved.Keywords: Human lens; Brunescent cataract; Ascorbic acid; Advanced glycation endproduct; Maillard reaction; Yellow chromophore; AgingAbbreviations: AGE, advanced glycation endproduct; BCA, bicinchoninic
acid; DTPA, diethylenetriaminepentaacetic acid; HFBA, heptafluorobutyric
acid; K2P, lysine–lysine pyridinium; LC/MS, reversed phase-high performance
liquid chromatography/electrospray ionization-mass spectrometry; MS/MS,
tandem mass spectrometry; PDA, photodiode array; Th, Thomson; WI, water-
insoluble fraction; WISS, water-insoluble sonicate supernatant; WS, water-
soluble fraction; 2-D, 2-dimensional
⁎ Corresponding author. Tel.: +1 573 882 6093; fax: +1 573 884 4868.
E-mail address: rongzc@yahoo.com (R. Cheng).
1 Present address: Neurosurgery Division, University of Missouri, 1 Hospital
Dr., Columbia, MO 65201, USA.
0925-4439/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2006.01.0091. Introduction
The aging of the human lens is characterized by an increase
in water-insoluble (WI) proteins associated with high levels of
yellow chromophores and non-tryptophan fluorescence [1–4].
These protein modifications are all enhanced in senile and
brunescent cataractous lenses. The glycation of lens proteins has
been suggested to be one of the major protein modifications
present in older lenses [5,6], and indeed diabetic patients are at
higher risk for cataract formation [7,8]. Due to the possibly life-
long stability of the lens crystallins, they can accumulate
damaging modifications continuously. In time, these may be
responsible for the protein aggregation, protein crosslinking and
eventually to age-onset cataract. A dramatically visible increase
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cataract formation especially in tropical countries [9,10].
Ascorbic acid is present in the human lens at relatively high
concentrations (up to 2 mM), which is higher than the normal
glucose levels in lens (∼1 mM) [11,12]. This is potentially
significant, because ascorbic acid has been shown to participate
in both glycation reactions [13] and the metal-dependent
generation of oxygen free radicals in vitro [14]. In vitro
incubation experiments have revealed that the oxidation
products of ascorbic acid can rapidly react with lens proteins
through glycation reactions to form cross-linked proteins with
characteristic browning and fluorescence [15,16]. These
changes resemble those occurring in the lens during normal
aging and cataract formation. The structures of several advanced
glycation endproducts (AGEs), such as pentosidine [17,18],
carboxymethyllysine [19], LM-1 (vesperlysine A) [20,21],
glucosepane [22] and K2P [23] are known, and have been
identified in human lens proteins. Similar compounds can be
formed by the reaction of lens proteins with ascorbic acid in
vitro, however, the exact glycating agent responsible for forming
these AGEs in vivo has yet to be identified with certainty.
In order to support a role for ascorbate glycation in lens
aging and cataract formation, it will be necessary to isolate the
AGEs from ascorbylated proteins, and show that several of
these are identical to the yellow, fluorescent compounds isolated
from both aged human and brunescent cataract lenses.
Previously, we reported that the yellow chromophores and
fluorophores in human cataractous lenses are chromatograph-
ically almost identical to those formed from in vitro ascorbyla-
tion of calf lens proteins [24] and all these yellow chromophores
increased quantitatively with age in the normal human lens
water-insoluble sonicate supernatant (WISS) proteins [25]. We
recently developed a new 2-dimensional LC-MS technique,
which allows us to analyze the total modified amino acids in
cataract lens protein digests and in digests of lens proteins
glycated by ascorbic acid in vitro. Furthermore, this technique
permits an LC-MS/MS analysis of the major modifications
present in these two preparations. It is anticipated that this
technique may provide the basis for a structural comparison of
the total Maillard reaction products obtained with ascorbic acid,
as well as many other protein modifications that accumulate
during aging and early brunescent cataract formation.
2. Materials and methods
2.1. Materials
Ascorbic acid (99.6% pure) was obtained from Fisher Chemical Co. (St.
Louis, MO). All other reagents were obtained in the highest purity available from
Sigma Chemical Co. (St. Louis, MO). De-ionized water (18 MΩ resistance or
greater) was used for all experiments. Phosphate buffers were treated with 10 g/L
Chelex resin (200–400 mesh, Bio-Rad Laboratories, Richmond, CA, U.S.A.) to
remove trace metal ion contaminants as described by Beyer and Fridovich [26],
and filtered through a 0.2-μm nitrocellulose filter before use.
Aged normal human lenses were obtained as a kind gift from the Heartland
Lions Eye Tissue Bank following cornea removal. Brunescent cataracts were
collected from hospitals in Rajkot, India and stored frozen at the Patney Eye
Clinic. After transported to Columbia, MO, they were stored individually frozen
at −70 °C until use.2.2. Preparation of lens proteins
Newborn calf lenses (1.0–1.2 g) were obtained from Pel-Freeze Biologicals,
Rogers, AR, shipped in dry ice and stored at −70 °C. The water-soluble (WS)
fraction was prepared from the outer cortex of thawed, decapsulated lenses by
removing the outer 1.0 cm of tissue with a cork borer. This tissue was
homogenized in deionized water with a hand Dounce homogenizer and the
resulting homogenate was centrifuged at 27,000×g for 20 min. The supernatant
was dialyzed extensively against water and used directly for glycation
experiments. The protein content of these calf lens protein preparations was
determined using the bicinchoninic acid (BCA) assay as described by the
manufacturer (Pierce, Rockford, IL).
Aged normal human lenses or early stage brunescent lenses (dark yellow to
tan in color) were decapsulated, pooled and homogenized in deionized water.
The 27,000×g pellet was obtained and washed three times with an equal volume
of deionized water to remove any trapped soluble proteins. The final pellet was
resuspended once again and sonicated in ice for 5 min in a Heat Systems-
Ultrasonics Inc. Sonicator (Model W-375) at a power setting of 4 and a duty
cycle of 40% [27]. The solubilized proteins were recovered after centrifugation
at 27,000×g, and the pellet was resuspended and sonicated again. The second
supernatant, when combined with the first, represented 95% of the total water-
insoluble (WI) fraction and was designated the WI sonicate supernatant (WISS)
as described previously [28].
2.3. Glycation reactions
Dialyzed calf lens cortical proteins (10 mg/ml) were incubated with 20 mM L-
ascorbic acid in 0.1 M Chelex-treated phosphate buffer (pH 7.0) containing 1.0 mM
DTPA. Each reaction mixture (∼200 ml) was sterile-filtered through a 0.22-μm
nylon syringe filter into a sterile plastic culture flask. Each flask was wrapped in
aluminum foil and incubated in the dark at 37 °C for 4 weeks in the presence of air,
with an air space of roughly twice the volume of the reaction mixture. The level of
ascorbic acid during a typical incubation was monitored by HPLC. Ascorbic acid
was still present after 2 weeks of incubation, but not after 4 weeks. The reaction
mixtures were then dialyzed extensively against 5 mM Chelex-treated phosphate
buffer, pH 7.0 at a ratio of 1 to 8 (v/v) for several changes.
2.4. Proteolytic digestion of ascorbylated calf lens proteins and
cataract lens proteins
Proteolytic digestionwas carried out by amodification of the method of Luthra
et al. [29]. Solutions containing 10 mg/ml of either pooled cataract WISS fractions
or dialyzed 4-week ascorbylated calf lens proteinswere prepared in 5.0mMChelex-
treated phosphate buffer, pH 7.0, and 3.6 mg of porcine intestinal peptidase (Sigma
P7500) was added per 100 mg protein. The digestion mixture was then sterile
filtered into a sterile tissue culture flask, bubbled with argon, and incubated for 24 h
at 37 °C in the dark. A solution of Pronase (Sigma P5147) was then added through a
syringe filter after 24 h to a level of 3.6 mg Pronase per 100 mg protein, and
digestion was continued for 72 h with two more additions of Pronase after 24 and
48 h, respectively. Following adjustment of the digest to pH 8.5 with 1.0 MNaOH,
leucine aminopeptidase (Sigma L 5658) was added to a final concentration of 40
units per 100 mg protein. The digest was sterile filtered, bubbled with argon and
incubated for 24 h at 37 °C. After adjusting the pH of the digest to 7.6 with 1.0 M
HCl, it was sterile filtered again, bubbled with argon, and further proteolysis carried
out by the sequential sterile addition of 5.0mg of trypsin per 100mg protein (Sigma
T8642), 5.0 mg chymotrypsin (Sigma C4149) and finally 3.6 mg Proteinase K
(Sigma P6556) per 100mg proteinwith 24 h between each addition. Corresponding
controls without protein were also treated with enzymes and analyzed on several
occasions. Amino acid analysis was used to evaluate the efficiency of the enzyme
digestion by comparing the total free amino acids in a 12% sulfosalicylic acid
supernatant to that of an equivalent aliquot acid hydrolyzed in 6.0 N HCl, for 20 h.
2.5. Bio-Gel P-2 size-exclusion chromatography
Digests from cataract WISS, aged normal human lens WISS or ascorbylated
calf lens proteins were concentrated and subjected to gel filtration chromatog-
raphy on a Bio-Gel P-2 column (5×76 cm, bed volume 1.5 L), with 25 mM
Fig. 1. Bio-Gel P-2 elution profiles of the proteolytic digest of a water insoluble sonicate supernatant (WISS) fraction from Indian cataract (A), a 4-week ascorbic acid
modified calf lens protein preparation (panel B), a aged normal human lens WISS fraction (panel C) and an un-modified calf lens protein control (D). The profiles for
absorbance at 330 nm and 350/450 nm fluorescence are labeled in each panel. The numbers shown identify the peaks which were pooled based upon 330 nm
absorbance.
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applied to the column and 14.5 ml fractions were collected at a flow rate of 1 ml
per minute. The collected fractions were monitored for absorbance at 330 nm
and for fluorescence at Ex/Em=350/450 nm. An enzymatic digest of
unmodified calf lens protein (control) was fractionated under the same
conditions. Peak fractions were pooled according to the A330 readings. Four
peaks (designated peak 1 to peak 4) were obtained.
2.6. LC-MS and LC-MS/MS
Peak 1, 2 and 3 were collected from the Bio-Gel P-2 column of digests of
pooled aged normal human lenses, early stage brunescent cataract lenses, and calf
lens proteins incubated in vitro with or without ascorbic acid in air. Both LC-MS
and LC-MS/MS analyses were performed with an in-line HPLC-TSQ 7000 mass
spectrometer (Thermo Finnigan, San Jose, CA) equipped with an electrospray
(ESI) interface. The LC system consists of a quaternary pump P4000, an auto
sampler AS3000 and a photo diode array detector UV6000LP. A Phenomenex
LUNA 5 μ C18 (2) 250×4.6 mm column was used for sample analysis. The
column was eluted for 2 min with 5% (v/v) acetonitrile in water containing 0.1%
(v/v) heptafluorobutyric acid (HFBA) (buffer A) at a flow rate of 0.6 ml perFig. 2. A comparison of HPLC-PDA profile (panel A) and 2-dimensional LC-MS ma
digest was injected to a RP-HPLC and monitored with photo diode array (PDA) orminute, and then with a linear gradient to 40% buffer B (100% acetonitrile
containing 0.1% (v/v) heptafluorobutyric acid (HFBA) over 40 min, followed by
a linear increase to 100% buffer B over the next 5 min. The eluant from the
column was monitored with an on-line photodiode array detector (PDA) and
directly introduced to a positive mode ESI-mass spectrometry as previously
reported [23].
Data were processed with the software pack Xcalibur 1.2. The masses of the
parent and daughter ions in the LC-MS and LC-MS/MS experiments described
belowweremeasuredwithin a ±0.5 Thomson (Th) window centered on themass-
to-charge ratio of interest. The collision energy used for theMS/MS analyses was
25 eV.3. Results
3.1. Bio-Gel P-2 chromatography of the lens protein digests
The washed WI fraction from Indian early stage brunescent
cataracts lenses and from aged normal eye bank lenses wasp profile (panel B). Aliquots of peak 1 isolated from cataract lens WISS protein
in-line ESI-mass spectrometry.
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proteolytic enzymes. Calf lens proteins incubated in the presence
and absence of ascorbic acid for 4 weeks under air were also
digested using the same procedure. Fig. 1 shows the Bio-Gel P-2
elution profiles of the proteolytic digests of water insoluble sonicate
supernatant (WISS) fraction from the early stage brunescent Indian
cataract (panel A), aged normal human lens WISS fraction (panel
C) and calf lens proteins modified for 4 weeks either with (panel B)
or without (panel D) added 20 mM ascorbic acid. The elution
profiles for the absorbance at 330 nm, the fluorescence at 350 nm
excitation/450 nm emission are labeled in each panel. The numbers
shown above the peaks identify those peaks, whichwere pooled for
LC-MS analysis based upon 330 nm absorbance. Peak 1 contained
all of the material eluting before the major amino acid peak,
whereas peaks 2 and 3 eluted with the main amino acid peak.
Almost identical elution profiles were observed for the preparations
of cataract lens protein digest, 4-week ascorbylated calf lens protein
digest and aged normal human lens protein digest, which is
consistent with our previous results [24]. Very few chromophores
and fluorophores were detected from the unmodified calf lens
protein digest (panel D), indicating that no chromophores were
either produced during the lengthy enzymatic digestion process or
contributed by the added enzymes. LC-MS controls for peaks 1 to 3
of unmodified calf lens protein digest were also collected by
pooling the same fractions as 4-week ascorbylated calf lens protein
digest (panel B); fractions 30 to 56, 57 to 62 and 63 to 71, for peaks
1, 2 and 3, respectively.
3.2. A comparison of HPLC-PDA profile and 2-D LC-MS maps
Previously, we showed a marked chromatographic similarity
between the yellow chromophores isolated from humanFig. 3. LC-MS map of the modified residues present in peak 1 obtained from digest
weeks (panel B), aged normal human lens WISS proteins (panel C) and un-modif
analyzed further by LC-ms/ms.cataracts and those from in vitro ascorbic acid-modified calf
lens proteins. Panel A of Fig. 2 shows the RP-HPLC elution
profile of peak 1 from a cataract lens digest as detected with the
photo diode array detector. A number of peaks were detected
eluting above a high background absorbance. Panel B shows the
same elution monitored for all species with a mass to charge
ratio (m/z) between 150 and 600 Th. This two-dimensional LC/
MS profile was designated as a 2-D LC-MS map of modified
amino acids. The “x” axis is the retention time on HPLC, the y
axis is the mass to charge (m/z) ratio of each modified residue.
The map determines the total modifications based on both
molecular mass and retention time, no matter whether the
product has a specific absorbance or not. Therefore, every spot
represents a unique modified residue. As shown in panel B,
multiple compounds can be detected and distinguished at the
same retention time. As an example, the highest peak at
27.7 min in panel A appeared as one spot in panel B (circled).
This residue has been structurally identified as a lysine–lysine
crosslink, named K2P, with a molecular mass of 370 Da as
reported recently [23]. Many other spots around K2P have
similar intensity based on the darkness of the spots, but were not
able to be seen as separate peaks by the UV detector. Therefore,
an LC-MS map provides more detailed information and is more
powerful than HPLC itself for the characterization of total
modified residues in a complex system.
3.3. LC-MS maps of major yellow peaks isolated from human
lenses or in vitro modified samples
Fig. 3 shows the LC-MS maps of the modified residues
present in peak 1 obtained from the digests of cataract lens
proteins (panel A), 4-week ascorbic acid modified calf lenss of cataract lens WISS proteins (panel A), calf lens proteins ascorbylated for 4
ied calf lens protein control (panel D). The numbers indicate these spots were
Fig. 4. LC-MS map of the modified residues present in peak 2 obtained from digests of cataract lens WISS proteins (panel A), calf lens proteins ascorbylated for 4
weeks (panel B), aged normal human lens WISS proteins (panel C) and un-modified calf lens protein control (panel D). The numbers indicate these spots were
analyzed further by LC-ms/ms.
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reacted calf lens protein control (panel D). As many as 38
different species were detected in peak 1 from the cataract
human lenses at a response factor of 105 or greater (panel A).
The width of each dash (spot) is equivalent to the width of the
eluting peak. Most of these species were also present as
prominent species in ascorbic acid modified CLP (panel B) andFig. 5. LC-MS map of the modified residues present in peak 3 obtained from digest
weeks (panel B), aged normal human lens WISS proteins (panel C) and un-modifi
analyzed further by LC-ms/ms.aged normal human lens proteins (panel C). The retention time
and the mass/charge ratio of each spot were determined, the
spots common to panels A, B and C with a response factor of
105 or greater are circled to allow comparison. A total of 74
spots were present in the cataract digest map of which 38 spots
were also present in the ascorbic acid-modified CLP. The spots
numbered from 1 to 9 were selected for further LC-MS/MSs of cataract lens WISS proteins (panel A), calf lens proteins ascorbylated for 4
ed calf lens protein control (panel D). The numbers indicate these spots were
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Calf lens protein incubated without ascorbic acid (D) exhibited
only two species at a response factor of 104 or greater. The
ladder patterns in panel D are instrument artifacts and these
spots, while common, are not circled in the other maps.
Fig. 4 shows the LC-MS maps of the modified residues
present in peak 2 obtained from digests of cataract lens proteins
(panel A), 4-week ascorbic acid modified calf lens proteins
(panel B), aged normal human lens (panel C) and un-reacted
calf lens protein control (panel D). As many as 31 species were
found to be identical. Within this group, eighteen species
numbered from 10 to 27 with response factors of 104 or greater
in peak 2 from cataract digest (A) and ascorbic acid modified
CLP (B) were submitted further for LC-MS/MS analysis. Very
few spots with response factor of 104 or greater were detected
from the calf lens protein digest (D).Fig. 6. SIM LC-MS analysis of a spot selected from the peak 1. One spot, which was
Panels A, B and C showed the selected ion monitor at m/z of 317 Da for this specific
(panel B) and un-modified calf lens protein (panel C), respectively.Fig. 5 shows the LC-MS maps of the modified residues
present in peak 3 obtained from digests of cataract lens proteins
(panel A), 4-week ascorbic acid modified calf lens proteins
(panel B), aged normal human lens (panel C) and un-reacted
calf lens protein control (panel D). As many as 35 species were
present at a response factor of 104 or greater in peak 3 from the
cataract and aged normal human lens digests, as well as present
as prominent species in the ascorbylated calf lens protein digest.
Twelve circled spots with numbers from 29 to 40 were
submitted further for LC-MS/MS analysis.
3.4. LC-MS/MS analysis of selected spots presented in peaks 1,
2 and 3
Totally, 40 spots at a response factor of 104 or greater were
selected from peaks 1, 2 and 3 for further LC-MS/MS analysislabeled with #1 from peak 1 (Fig. 3), was selected to run LC-MS/MS analysis.
residue from peak 1 of cataract (panel A), 4-week ascorbylated calf lens protein
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showed one example of SIM LC-MS analysis for a selected
spot which has mass to charge ratio (m/z) of 317 Da, and
labeled as #1 in peak 1 (Fig. 3). Obviously, a signal with the
same retention time (∼27 min) and same mass to charge ratio
(m/z, 317 Da) was detected from both cataract lens protein
digest (panel A) and ascorbylated calf lens protein digest (panel
B), but it was not detectable in un-reacted calf lens protein
digest (panel C).
Fig. 7 showed LC-MS/MS results of this residue from
cataract lens protein digest (panel A) and ascorbic acid modified
calf lens protein digest (panel B), respectively. The parent ion
(m/z 317 Da) and numerous daughter ions (282, 229, 175, 158,
143, 116, 115 and 70 Da) were detected and they were identical.
Based on the fragmentation pattern, this residue is not a
dipeptide because the mass of a normal amino acid was not
detected. However, the basic fragments of 70 and 116 suggested
this residue might be a modified arginine or ornithine [42].Fig. 7. LC-MS/MS fragmentation results for the selectedm/z of 317 Da species from cThese spectra confirm that this modified residue found in
cataract lens proteins arises from ascorbic acid modification.
LC/MS-MS analysis of the 40 species selected from both
cataract lens protein digest and ascorbic acid-modified calf lens
protein showed that 36 species were identical. These MS/MS
results are summarized in Tables 1, 2 and 3 for each peak,
respectively. As shown in the Tables, the response factor for
each residue and the major fragments derived from the
degradation of each residue are listed. The residues with the
same molecule mass but with a different fragmentation pattern
are labeled with an asterisk.
4. Discussion
Aging in the human lens is characterized by the accumula-
tion of protein-bound yellow chromophores and fluorophores,
associated with an increase in protein aggregation and protein
crosslinking. Several of these chromophores, either Trpataract lens protein (panel A) and 4-week ascorbylated calf lens protein (panel B).
Table 1
LC-MS/MS fragmentations of selected spots from peak 1
No. m/z Cataract P1 Asa-CLP P1
Response Factor Fragments (Daughter ions) Fragments (Daughter ions) Response Factor
1 317 1.72E6 282, 229, 175, 158, 143, 116, 70 282,229,175,158,143,116,71 4.70E5
2 207 1.90E6 166, 120, 103 166,120,103 1.29E6
3 288 1.19E6 189, 171143, 118, 72 189,171143,118,72 9.10E5
4 371 1.40E6 326, 281, 215 326,281,215 1.00E5
5 244 3.43E6 203, 157, 132, 86 203,157,132,86 1.44E6
6 801 5.70E6 694, 588, 514 694,588,513,253 9.80E5
7 231 6.00E6 132, 86, 72, 55 132,86,72,55 2.79E6
8 245 4.69E6 138, 132, 86 138,132,86 3.00E6
9 262* 4.80E5 162, 102, 85 245,221,203,162,136,107,102,85 6.20E5
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[17–23], have been isolated, and their structures determined.
Modified amino acids can also arise by phosphorylation,
deamidation, isomerization, oxidation and reactions with
dehydroalanine residues or reactions of Trp oxidation products
with several amino acid residues, however, the total modifica-
tions are not known [38–41]. A significant challenge, therefore,
remains to determine the number of these protein modifications,
their structures and the mechanisms that give rise to these
modifications.
Prior results from our laboratory have argued for a major role
for ascorbic acid oxidation products in AGE formation in vivo.
Ascorbic acid, in air, glycated lens proteins 9-fold, and
crosslinked proteins 90-fold more rapidly than either glucose
or fructose [33]. Lens proteins incubated with ascorbic acid for
4 weeks exhibited the same absorption and fluorescence spectra
as the proteins present in a human lens WI fraction [34]. The
link between ascorbic acid-induced advanced glycation end
products (AGEs) and the chromophores and fluorophores
present in cataract lens proteins was strengthened by showing
that the HPLC chromatographic profiles of digests of these twoTable 2
LC-MS/MS fragmentations of selected spots from peak 2
No. m/z Cataract P2
Response Factor Fragments (Daughter i
10 234 2.10E4 193,188,151,119,103,7
11 191 4.60E4 150,133,104,88
12 216 1.00E5 198,174,157,129,102,8
13 249 4.00E4 148,130,102
14 219 1.10E5 130,90
15 301* 1.10E4 102
16 402* 2.50E4 384,366,255,209,191,1
17 235 3.50E5 217,146,130,116,106,8
18 369 1.50E4 351,281,102
19 130* 1.80E5 89,72,70
20 455 1.60E4 314,228,130,102
21 144 1.63E5 103,86,74
22 247 2.61E5 206,183,116,86,70
23 459 8.45E4 328,144,102
24 501 1.05E4 403,370,156
25 185 1.20E4 144,102,84,70
26 245 1.53E5 204,181,86
27 287 3.17E4 246,200,156,128,102,8protein preparations were essentially identical [24]. The data
presented here provide LC/MS and LC/MS/MS evidence that
half of the total modified amino acids in human cataract lens
proteins can be produced by ascorbate glycation of lens proteins
in vitro. The presence of DTPA in our vitro system likely
prevents hydroxyl radical formation, but superoxide and
hydrogen peroxide formations are possible. We also point out,
however, that simple oxidation products of amino acids would
be excluded in our analysis as their molecular weight would be
less than the exclusion limit set on our mass spectrometer,
except for dityrosine, whose presence remains controversial in
lens proteins.
Since AGEs are widely thought to be acid labile, and because
acid hydrolysis produces a myriad of yellow fluorescent Trp
degradation products, we chose to use an enzymatic hydrolysis
method to release the modified amino acids from lens proteins.
Based on our previous data, this enzymatic digestion procedure
releases at least 95% free amino acids from both the cataract and
ascorbylated lens proteins [24]. Oxidative degradation of
constitutive amino acids was kept to a minimum by the
presence of ascorbic acid throughout the glycation reactions,Asa-CLP P2
ons) Fragments (Daughter ions) Response Factor
9 193,188,151,119,103,80 7.24E4
150,133,104,88 1.49E5
6,72,44 198,174,157,129,102,86,72,45 4.85E5
148,130,102 4.97E4
130,90 6.21E4
260,212,172,102 8.30E5
60 384,361,320,227,133,101 2.90E4
4 217,146,130,116,106,85 1.23E6
351,281,102 9.02E5
85,84 1.10E5
314,228,130,102 2.53E4
103,86,74 6.64E4
206,183,116,86,70 2.30E4
328,144,102 6.80E4
403,370,156 6.60E4
144,102,84,70 4.90E4
204,181,86 2.70E5
6 246,200,156,128,102,87 3.50E4
Table 3
LC-MS/MS fragmentations of selected spots from peak 3
No. m/z Cataract P3 Asa-CLP P3
Response Factor Fragments (Daughter ions) Fragments (Daughter ions) Response Factor
28 161 1.48E6 120,102,84,74,56 120,102,84,74,55 6.8E5
29 249 1.34E6 120,102,74 120,102,74 3.80E5
30 463 4.30E4 334,259,205,148,130,76 334,259,205,148,130,75 3.70E4
31 507 3.90E4 249,148,120 249,148,120 3.20E4
32 429 3.20E4 259,174 259,174 2.60E4
33 517 2.70E4 338,303,259,174 338,303,259,174 4.10E4
34 543 1.20E5 429,290 388,303,259,174 8.30E4
35 568 2.80E4 527,354,291 527,354,291 2.60E4
36 177 2.20E5 119,90,73 119,90,73 2.90E4
37 156 2.12E6 110,93,83,70 110,93,83,70 1.59E6
38 219 4.17E6 118,101,72 118,101,72 9.50E4
39 173 6.33E6 132,86,69 132,86,69 3.69E6
40 445 6.20E4 314,130,102 314,130,102 3.40E4
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in the dark at all times.
The fractionation of the lens protein digests by Bio-Gel P-2
chromatography shown in Fig. 1 resolved the major yellow
chromophores into four A330-absorbing peaks. The initial broad
peak (peak 1) may contain protein crosslinks and represented
25–30% of the total A330 absorbance. Peak 2 and 3 together
represent 40–50% of the total A330 absorbance and contain most
of the modified residues and free amino acids. The P-2 profiles
shown is typical of 6 different preparations of cataract water
insoluble proteins, 4 different preparations of ascorbic acid
modified proteins, 3 different preparations of aged normal
human lens proteins and 3 unmodified calf lens protein controls.
Further, the P-2 column was eluted under acidic conditions to
prevent further reaction of any AGE products, and the major
peak 1, 2 and 3 were stored in concentrated form under argon in
the cold until submitted for LC-MS analysis. Peak 4 contains
only aromatic amino acids and was not analyzed.
By using the LC/MS unique technique, the total modified
amino acids in peaks 1, 2 and 3 from cataract lens, aged normal
human lens and calf lens protein modified with or without
ascorbic acid were analyzed (Figs. 3–5). Numerous spots which
have the same retention time and molecular mass were
identified in each peak and circled in each panel. The 2D map
profiles shown are typical of 3 different preparations of cataract
water insoluble lens proteins, 2 of ascorbic acid modified
proteins and 2 of aged normal human lens proteins. Eighty three
to 88% identities were obtained for the maps from three samples
of pooled type I cataract lens proteins prepared separately.
Furthermore, 66% of the major spots detected by their response
factor in cataract lens protein digest peaks were also detected in
ascorbic acid modified calf lens protein digest due to
ascorbylation, which is consistent with our previous analysis
by HPLC [24].
It must be noted that the spot labeled with #4 in Fig. 3 was
recently isolated and structurally identified as a novel crosslink
[23]. Its structure was assigned as 1-(5-amino-5-carboxypen-
tyl)-4-(5-amino-5-carboxylpentylamino)-3-hydroxy-2, 3-dihy-
dropyridinium with molecular mass of 370 Da. Several otherspots are under investigation. By comparison of the three P-2
chromatography peaks from cataract lens and ascorbic acid
modified calf lens protein digests by this 2-D LC/MS map
technique (Figs. 3, 4 and 5), more than 100 spots can be
confirmed to be identical. This high number is significant
because all the known AGEs analyzed in human lens to date
range from 10 to 500 pmol/mg lens protein. If there are 100
spots due to AGEs, the total AGE modifications could approach
40 nmol/mg lens protein, or about 1 modification per crystallin
subunit.
Our previous data indicated that our current enzymatic digest
procedure releases at least 95% free amino acids from both
cataract lens proteins and ascorbic acid modified calf lens
proteins, however, in order to confirm the spots which were
circled in each panel are not incompletely digested peptides. A
total of 40 spots were selected from peak 1, 2 and 3 and
analyzed further by SIM LC-MS and LC-MS/MS. A typical
example was shown in Figs. 6 and 7. The response factors for
each spot and all the major fragments generated from ms/ms
analysis were summarized in Tables 1, 2 and 3. Of the 40 major
spots analyzed by MS/MS in cataract lens proteins, 90% were
identical to those in the ascorbic acid modified calf lens
proteins. Furthermore, the fragmentation pattern of these spots
revealed that these spots are not undigested peptides; they are
either modified amino acids or crosslinks.
Recently, considerable evidence has been published support-
ing the binding of UV filter compounds (E.G. 3-hydroxykynur-
enine glycoside) to lens proteins as having a major role in the
formation of the chromophores and fluorophores present in
aged human lenses and cataracts [35–37]. Also, dehydroalanine
crosslinks have been identified in cataract lens proteins.
Analysis by selected ion monitor (SIM) technique shows
signals corresponding to the mass of the three dehydroalanine
adducts. Signals were also seen for Kyn-His and Kyn-Lys,
however, Kyn-Cys may have dissociated during our sample
preparation, which includes an incubation at pH 8.5 for 24 h.
The evidence presented here argues that the bulk of modifica-
tions likely arise by ascorbic acid glycation. The low reactivity
of glucose and fructose argue that these sugars are not
542 R. Cheng et al. / Biochimica et Biophysica Acta 1762 (2006) 533–543significant contributors to the AGEs in the lens [33,38].
Actually, we have incubated calf lens proteins with glucose,
fructose, ribose, erythrulose, glyceraldehydes, glycolaldehyde
and methyl glyoxal. All of the 2-D mass spectra were much
simpler with only a few matches to the cataract samples. These
data will be the subject of our next paper.
Hopefully, this work provides general methods, which can be
employed in the future, to identify individual modified amino
acids which develop with aging in vivo and during glycation
reactions in vitro. An LC/MS analysis in this manner can be
used to obtain a complete picture of the Maillard reaction
products obtained with different carbonyl compounds, as well
as the protein modifications that accumulate during aging.
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